WC
The startup develops mass-produced cell immunotherapies for cancer treatment, utilizing advanced cellular therapy techniques to enhance patient access to effective therapies. By providing generic cellular products, the company addresses the high costs and limited availability of personalized cancer treatments.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops mass-produced cell immunotherapies for cancer treatment, utilizing advanced cellular therapy techniques to enhance patient access to effective therapies. By providing generic cellular products, the company addresses the high costs and limited availability of personalized cancer treatments.